CD79A and irritable bowel syndrome: Recent studies found that bacteria enriched by IgA-seq were directly involved in the development of inflammation, inflammatory bowel disease (IBD) [44], and spondyloarthritis [45], Oral W27 IgA, an IgA that specifically binds to non-beneficial bacteria, is a potential treatment for IBS [46].